Selected article for: "absolute number and acute aki kidney injury"

Author: El-Sayed, Enass E.; Allayeh, Abdou K.; Salem, Amany A.; Omar, Sheren M.; Zaghlol, Salwa M.; Abd-Elmaguid, Hala M.; Abdul-Ghaffar, Mohammed M.; ElSharkawy, Magdy M.
Title: Incidence of acute kidney injury among COVID-19 patients in Egypt
  • Cord-id: 1sokyqsl
  • Document date: 2021_6_14
  • ID: 1sokyqsl
    Snippet: BACKGROUND: Despite the fact that the fundamental characteristics of coronavirus disease-2019 (COVID-19) are respiratory manifestations, multi-organ failure including the kidney has been documented. There are no clear comparisons of COVID-19 cases with and without acute kidney injury (AKI) to show whether there are aspects of acute kidney injury progression path or outcome that are unique to this disease. METHODS: In this work, we analyzed the data of 734 COVID-19 cases admitted to the Ahmad Mah
    Document: BACKGROUND: Despite the fact that the fundamental characteristics of coronavirus disease-2019 (COVID-19) are respiratory manifestations, multi-organ failure including the kidney has been documented. There are no clear comparisons of COVID-19 cases with and without acute kidney injury (AKI) to show whether there are aspects of acute kidney injury progression path or outcome that are unique to this disease. METHODS: In this work, we analyzed the data of 734 COVID-19 cases admitted to the Ahmad Maher Teaching Hospital in Cairo, Egypt, between June 6 and July 25, 2020. Data on demographics, comorbidities, laboratory results, and outcomes were assessed. To assess the incidence rate of AKI in Egyptian COVID-19 patients, comparisons were carried out between home-isolated COVID-19 patients, hospitalized COVID-19 patients, and ICU COVID-19-patients with or without AKI. RESULTS: AKI was more common in hospitalized mild COVID-19 patients than in home-isolated and ICU COVID-19 patients (15.0% versus 10.8% and 14.2%, respectively). The overall occurrence rate of AKI was significantly higher in COVID-19 patients (n=91, 14%). Hemodialysis, on the other hand, was required in 76% of the extreme ICU COVID-19 patients who developed AKI (22/29). The absolute number of patients with AKI COVID-19 who required hemodialysis was 34 (37%). This accounted for 5.2% of all COVID-19 patients and 37% of those with AKI. The mortality rate in COVID-19 patients with or without AKI was 15.4% and 4.8%, respectively. CONCLUSION: AKI in our COVID-19 patients is associated with a high mortality rate in ICU-COVID-19 patients. Our findings suggest that COVID-19 patients, particularly ICU COVID-19 patients, should be closely monitored for the development of AKI. Early identification of AKI, as well as prompt intervention, can improve COVID-19 patient outcomes.

    Search related documents:
    Co phrase search for related documents
    • absolute number and liver kidney: 1
    • absolute number and low income: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and liver kidney function: 1
    • acute ards respiratory distress syndrome and low income: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and low morbidity: 1, 2
    • acute ards respiratory distress syndrome and lung renal: 1, 2, 3, 4, 5, 6
    • acute kidney disease and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute kidney disease and low income: 1
    • acute kidney disease and lung renal: 1
    • acute kidney injury and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute kidney injury and liver kidney function: 1, 2
    • acute kidney injury and low income: 1, 2, 3, 4, 5
    • acute kidney injury and low income community: 1
    • acute kidney injury and lung renal: 1, 2, 3, 4, 5, 6
    • acute kidney injury develop and liver kidney: 1
    • acute patient kidney injury and liver kidney: 1, 2
    • liver kidney and low income: 1, 2
    • liver kidney and lung renal: 1, 2, 3, 4